Physician profile
Andrew K Day
NPI 1891791695
$3,756.20
in general payments reported to CMS, 2019-2025
19 companies · $1,569 in 2025
The $1,569 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $637 · 2021: $179 · 2022: $560 · 2023: $276 · 2024: $258 · 2025: $1,569.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,077 · Travel and Lodging: $1,003 · Education: $22.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,077.27 |
| Travel and Lodging | $1,002.88 |
| Education | $22.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,734.99 | 2019-2025 | Accent, Aveir, Assurity |
| Medtronic, INC. | $362.96 | 2024-2025 | Symplicity G3, Onyx Frontier, Intellis Adaptivestim |
| Medtronic Vascular, INC. | $361.56 | 2019-2020 | |
| Shockwave Medical, INC | $190.85 | 2020 | |
| Abiomed | $174.17 | 2019-2023 | Impella |
| Boston Scientific Corporation | $169.86 | 2020-2023 | Lux-Dx Insertable Cardiac Monitor, Valitude Crt-P |
| Impulse Dynamics (USA) INC. | $130.82 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $125.10 | 2022-2024 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $109.65 | 2023 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $76.30 | 2019-2023 | Uptravi |
| W. L. Gore & Associates, INC. | $54.59 | 2019 | |
| Novartis Pharmaceuticals Corporation | $51.88 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $43.42 | 2019-2021 | |
| Bard Peripheral Vascular, INC. | $34.75 | 2025 | Rotarexs 6 F X 135 Cm |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.44 | 2019-2025 | Lifevest |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bracco Diagnostics INC. | $30.14 | 2025 | |
| Angiodynamics, INC. | $24.79 | 2022 | |
| Cardiovascular Systems INC. | $23.47 | 2020 | |
| Sanofi-Aventis U.S. LLC | $22.46 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Day listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.